Cargando…
Metformin directly suppresses atherosclerosis in normoglycaemic mice via haematopoietic adenosine monophosphate-activated protein kinase
AIMS: Atherosclerotic vascular disease has an inflammatory pathogenesis. Heme from intraplaque haemorrhage may drive a protective and pro-resolving macrophage M2-like phenotype, Mhem, via AMPK and activating transcription factor 1 (ATF1). The antidiabetic drug metformin may also activate AMPK-depend...
Autores principales: | Seneviratne, Anusha, Cave, Luke, Hyde, Gareth, Moestrup, Soren Kragh, Carling, David, Mason, Justin C, Haskard, Dorian O, Boyle, Joseph James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064441/ https://www.ncbi.nlm.nih.gov/pubmed/32667970 http://dx.doi.org/10.1093/cvr/cvaa171 |
Ejemplares similares
-
Hematoma Resolution In Vivo Is Directed by Activating Transcription Factor 1
por: Seneviratne, Anusha, et al.
Publicado: (2020) -
Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals—a Swedish population-based study
por: Östgren, Carl Johan, et al.
Publicado: (2023) -
Structure of Klebsiella pneumoniae adenosine monophosphate nucleosidase
por: Richardson, Brian C., et al.
Publicado: (2022) -
The stable cyclic adenosine monophosphate analogue, dibutyryl cyclo-adenosine monophosphate (bucladesine), is active in a model of acute skin inflammation
por: Rundfeldt, Chris, et al.
Publicado: (2012) -
Metformin and incretin-based therapies up-regulate central and peripheral Adenosine monophosphate-activated protein affecting appetite and metabolism
por: Nakano, Masako, et al.
Publicado: (2012)